Morphometric Assessment of Pancreatic Atrophy: A Quantitative Classification Utilizing CT and MRI Imaging Techniques in Istanbul - Scorecard - MDSpire

Morphometric Assessment of Pancreatic Atrophy: A Quantitative Classification Utilizing CT and MRI Imaging Techniques in Istanbul

  • By

  • Fatih Öner Kaya

  • Esra Ümmühan Mermi

  • Alev Öztürk Günaldı

  • Haydar Kaan Karataş

  • Uğur Can Demir

  • Pınar Mert

  • Hüseyin Öztürk

  • Şule Sena Mazlum

  • Çağdaş Enginoğlu

  • April 22, 2026

  • 0 min

Share

Clinical Scorecard: Morphometric Assessment of Pancreatic Atrophy: A Quantitative Classification Utilizing CT and MRI Imaging Techniques in Istanbul

At a Glance

CategoryDetail
ConditionPancreatic Atrophy (PA)
Key MechanismsProgressive reduction in pancreatic parenchymal volume, acinar cell loss, fibrosis, and fatty infiltration.
Target PopulationIndividuals with chronic inflammatory diseases, metabolic disturbances, and physiological aging.
Care SettingRadiology departments utilizing CT and MRI imaging.

Key Highlights

  • Introduction of the İstanbul Morphometric Pancreatic Atrophy Classification (IM-PAC) as a four-tier grading system.
  • Significant association between IM-PAC grades and severity of ductal abnormalities and MRI-defined fibrosis.
  • Excellent inter-observer agreement for thickness measurements (ICC = 0.89).
  • Quantitative assessment improves reliability over subjective qualitative descriptions.

Guideline-Based Recommendations

Diagnosis

  • Utilize IM-PAC for standardized assessment of pancreatic atrophy.

Management

  • Integrate imaging findings with clinical features for comprehensive patient management.

Monitoring & Follow-up

  • Regular follow-up imaging to assess progression of pancreatic atrophy.

Risks

  • Consider risk factors such as age, sex, and metabolic disorders in evaluating pancreatic atrophy.

Patient & Prescribing Data

Patients with chronic pancreatitis, diabetes, obesity, and other metabolic disorders.

Management strategies should address underlying causes of pancreatic atrophy and associated metabolic conditions.

Clinical Best Practices

  • Adopt quantitative imaging techniques for accurate assessment of pancreatic morphology.
  • Ensure consistent use of IM-PAC grading in clinical practice to reduce inter-observer variability.

References

Original Source(s)

Related Content